FDA head says working with India to improve drug quality, safety

Tags: FDA, News
The U.S. Food and Drug Administration is working with Indian regulators to enhance the quality and safety of drugs made there, the FDA's Commissioner Margaret Hamburg said on Tuesday.

Hamburg also urged Indian regulators to work closely with their foreign peers.

Hamburg was speaking to reporters at the end of a visit to India which follows FDA decisions to ban the shipment of drugs to the United States from plants of leading Indian drugmakers including Ranbaxy Laboratories Ltd and Wockhardt Ltd .

During a visit that started on February 10, Hamburg met the Indian drugs regulator and health ministry officials as well as executives of local drugmakers.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.

EDITORIAL OF THE DAY

  • India would have done well not to supress the 'Bofors interview'

    Bofors is one case that refuses to go away two-and-half decades after it grabbed public attention and became a byword for political corruption, claimi

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Amita Sharma

The rabbit hole of outcome budgets

Would you tell me, please, which way I ought to ...

Zehra Naqvi

Dignity of labour is dignity of life

M Rafi Khan, a retired police IG, used to ...

Gautam Gupta

Retailers have it tough, thanks to e-commerce

For the past few months our focus has been on ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture